NEW YORK ( TheStreet) -- Santarus (Nasdaq: SNTS) hit a new 52-week high Friday as it is currently trading at $6.54, above its previous 52-week high of $6.50 with 329,808 shares traded as of 12:35 p.m. ET. Average volume has been 397,500 shares over the past 30 days. Santarus has a market cap of $394.4 million and is part of the health care sector and drugs industry. Shares are up 95.2% year to date as of the close of trading on Thursday. Santarus, Inc., a specialty biopharmaceutical company, engages in acquiring, developing, and commercializing proprietary products that address the needs of patients treated by physician specialists. The company has a P/E ratio of 70, below the average drugs industry P/E ratio of 90 and above the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter